RET Proto-Oncogene, Full Gene Analysis

Message
*Draw Monday-Thursday before 2:30pm. Do not collect on weekends or holidays.


Test Code
LAB00460


Alias/See Also
LAB00460
Mayo TC: RETZZ
Mayo Test Name: Multiple Endocrine Neoplasia Type 2 Syndrome, RET, Full Gene Analysis, Varies


CPT Codes
81406

Physician Attestation of Informed Consent
Providers: Informed consent and education are required prior to drawing specimen! Please see Instructions below.


Preferred Specimen
3.0 mL Lavender (EDTA) - Whole Blood


Minimum Volume
1.0 mL Lavender (EDTA) - Whole Blood


Other Acceptable Specimens
Yellow Top (ACD) - Whole Blood


Instructions


Transport Temperature
Room Temperature


Specimen Stability
Room Temperature: 4 days


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.


Methodology
Sequence Capture and Targeted Next-Generation Sequencing (NGS) followed by Polymerase Chain Reaction (PCR) and Sanger Sequencing

Report Available
21-28 days


Clinical Significance
Evaluating patients with a personal or family history suggestive of a multiple endocrine neoplasia type 2 (MEN2) or Hirschsprung disease (HSCR).
Establishing a diagnosis of MEN2 or HSCR allowing for targeted cancer surveillance based on associated risks.
Identifying varients within genes known to be associated with MEN2 or HSCR allowing for predictive testing of at-risk family members.


Performing Laboratory
Mayo Clinic



The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.